250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Biotechnology Startup Investors in Finland in July 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Finland. We rank investors based on the number of investments they made in Biotechnology companies from Finland. We update this investor list every month.

Top 50 Biotechnology Startup Investors in Finland in July 2025

Investor Biotechnology Finland investments
Business Finland 10
Tesi 9
Voima Ventures 9
Lifeline Ventures 9
Finnvera Venture Capital 8
Butterfly Ventures 5
Springvest 5
Icebreaker.vc 4
Innovestor 3
Stephen Industries 3
Nordic Foodtech VC 3
Sofinnova Partners 2
EQT Life Sciences 2
Leena Niemistö 2
Nordic Science Investments 2
Sauli Törmälä 2
HealthCap 2
Pontos Group 2
European Investment Bank 2
Broadview Ventures 2
Finnish Climate Fund 2
Fazer 2
VTT Ventures 2
Sitra 2
Inventure 2
Lynx Capital 1
Valio 1
Loudspring 1
Moomin Characters 1
Kiilto Ventures 1
XR Invest 1
KPMG 1
Unifund 1
Haakon Overli 1
Eqvitec 1
Novartis Venture Fund 1
K5 Global 1
Feroz Dewan 1
Creathor Ventures 1
Green Campus Innovations Oy 1
HTGF (High-Tech Gruenderfonds) 1
Ananda Impact Ventures 1
Aqua Spark 1
CPT Capital 1
Athensmed 1
Stockholm Techstars Accelerator 1
University of Helsinki 1
Petri Pöyhönen 1
H&M Group Ventures 1
Granström Mari 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Business Finland VC Fund · Helsinki, Southern Finland, Finland · 20 investments in the past 12 months
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Grant, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • AIATELLA — Automating medical image analysis
  • SparkReceipt — AI-powered Receipt Scanner and Expense Tracker for Individuals and Small Businesses. Create your free account now!
  • University of Eastern Finland — The University of Eastern Finland is a multidisciplinary university which offers teaching in more than 100 major subjects. The university comprises four faculties: the Philosophical Faculty, the Faculty of Science and Forestry, the Faculty of Health Sciences, and the Faculty of Social Sciences and Business Studies.
Tesi VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more
Investment focus
  • Software, Manufacturing, Health Care
  • Funding Round, Series A, Series B
  • Finland, United States, Argentina
Portfolio highlights
  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Steady Energy — Steady Energy aims to decarbonize the energy-intensive heating industry starting with residential and district heating.
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Voima Ventures VC Fund · Helsinki, Southern Finland, Finland · 11 investments in the past 12 months
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Seed, Pre-Seed, Funding Round
  • Finland, Sweden, Norway
Portfolio highlights
  • Hormona — Understand your hormones with the Hormona app. Monitor hormone levels, track symptoms, forecast cycles, and access personalized wellness tips for a balanced life.
  • Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Lifeline Ventures VC Fund · Helsinki, Southern Finland, Finland · 14 investments in the past 12 months
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Series A, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • Swarmia — Build better software faster with insights that power your whole engineering organization. Get started with a demo or a free 14-day trial.
  • Inven — Save time by using AI to find companies. Inven scans millions of websites to provide comprehensive data on companies similar to your search criteria.
  • Ovido — Ovido company specialises in supply chain and product data automation, with a focus on providing full product traceability and the establishment of Digital Product Passports (DPPs).
Finnvera Venture Capital VC Fund · Kuopio, Eastern Finland, Finland
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Finland, United States, Switzerland
Portfolio highlights
  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Butterfly Ventures VC Fund · Oulu, Oulu, Finland · 4 investments in the past 12 months
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Finland, Sweden, Norway
Portfolio highlights
  • Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
  • Brightplus Oy — Brightplus is an innovative renewable materials manufacturing company from Finland. We specialise in design and development of new functional properties for industrial biomaterial solutions. We cater for industries like packaging, construction, cosmetics and consumer goods. Our expertise is based on developing solutions to multiple industries andproviding fast prototyping and full fit for customers’ production lines. Our deep chemical BrightBio® technology creates an optimal fit between coatings, barriers and plastic replacing materials to help you in raising your material functionality to the next level.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Springvest VC Fund · Helsinki, Southern Finland, Finland
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Series A, Funding Round, Seed
  • Finland
Portfolio highlights
  • Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Icebreaker.vc VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • Finland, Estonia, Sweden
Portfolio highlights
  • Aibidia — Discover the Aibidia TXM Platform and our digital transfer pricing applications, eliminating billions of euros in tax inefficiencies and risks.
  • Crewpoint — Crewpoint specially designed tools that are adapted to the intricacies of maritime logistics our platform streamlines crew movements. We assist operations teams in providing seamless, effective staff changes worldwide, from bulk reservations and last-minute reroutes to round-the-clock assistance and real-time travel statistics.
  • Clock & Cloud — AI-driven platform delivering actionable geopolitical intelligence for proactive decision-making and enhanced business security
Innovestor VC Fund · Helsinki, Southern Finland, Finland · 10 investments in the past 12 months
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more
Investment focus
  • Software, Health Care, Manufacturing
  • Seed, Funding Round, Series A
  • Finland, Denmark, Sweden
Portfolio highlights
  • Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
  • Bahn Express — Fast and Effortless Car Transport
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Stephen Industries VC Fund · Espoo, Southern Finland, Finland · 5 investments in the past 12 months
We fund futurebreakthroughs
Show more
Investment focus
  • Apps, Water, Energy
  • Seed, Funding Round, Series A
  • Finland
Portfolio highlights
  • StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
  • HYPERMINE — Hypermine a novel laser-based mineralogy sensing technology to optimize resource recovery and reduce the negative environmental effects of mining.
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Nordic Foodtech VC VC Fund · Helsinki, Southern Finland, Finland · 2 investments in the past 12 months
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more
Investment focus
  • Biotechnology, Life Science, Water
  • Seed, Series A, Funding Round
  • Finland, Sweden, Denmark
Portfolio highlights
  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
  • Happy Plant Protein — Changing the way plant proteins are made
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 18 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • SafeHeal — SafeHeal is a clinical stage medical device manufacturer focusing on the development of anastomosis protection devices, including Colovac, for colorectal surgery.
  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 11 investments in the past 12 months
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
Leena Niemistö Angel · Helsinki, Southern Finland, Finland
Leena Niemistö
Show more
Investment focus
  • Health Care, Software, E-Commerce
  • Seed, Funding Round, Pre-Seed
  • Finland, United States
Portfolio highlights
  • Rens Original — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
  • Maire — Maire - AI co-pilot for industry leading B2C E-commerce brands. From Industry Trends to Market Research and Search Intent Analysis
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Nordic Science Investments VC Fund · 7 investments in the past 12 months
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more
Investment focus
  • Apps, Food Processing, Food and Beverage
  • Seed
  • Finland
Portfolio highlights
  • AIATELLA — Automating medical image analysis
  • Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
  • SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Sauli Törmälä Angel · Helsinki, Southern Finland, Finland
Sauli Törmälä is the Board Member, CFO at Promilless Oy. He attended University of Oulu.
Show more
Investment focus
  • Life Science, Biotechnology
  • Seed
  • Finland
Portfolio highlights
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in the past 12 months
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Pontos Group VC Fund · Helsinki, Southern Finland, Finland
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more
Investment focus
  • Genetics, Hospital, Automotive
  • Funding Round
  • Finland
Portfolio highlights
  • R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
  • Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
  • Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 25 investments in the past 12 months
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more
Investment focus
  • Biotechnology, Health Care, Energy
  • Debt Financing, Post-IPO Debt, Funding Round
  • Germany, France, The Netherlands
Portfolio highlights
  • Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
  • Greenlight Biosciences — Next Generation Crop Protection
  • Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
Broadview Ventures VC Fund · Boston, Massachusetts, United States · 2 investments in the past 12 months
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Debt Financing
  • United States, Israel, Denmark
Portfolio highlights
  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Finnish Climate Fund VC Fund · Helsinki, Southern Finland, Finland · 2 investments in the past 12 months
The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.
Show more
Investment focus
  • Energy, Renewable Energy, Sustainability
  • Debt Financing, Funding Round, Series A
  • Finland
Portfolio highlights
  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Fazer VC Fund · Vantaa, Southern Finland, Finland
Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.
Show more
Investment focus
  • Biotechnology, Food Processing
  • Series A, Series B, Funding Round
  • Finland
Portfolio highlights
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
VTT Ventures VC Fund · Espoo, Southern Finland, Finland
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more
Investment focus
  • Biotechnology, Manufacturing, 3D Technology
  • Seed, Funding Round, Series A
  • Finland
Portfolio highlights
  • Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Sitra VC Fund · Helsinki, Southern Finland, Finland
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more
Investment focus
  • Health Care, Biotechnology, Therapeutics
  • Funding Round, Series A, Series C
  • Finland, The Netherlands
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • SET Ventures — Europe's leading energy VC since 2007. Backing the continent's most innovative energy entrepreneurs with capital, community and insights
Inventure VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • Finland, Sweden, Denmark
Portfolio highlights
  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
  • Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Lynx Capital VC Fund · Shanghai, Shanghai, China
cross-border, healthcare, life science, investment, VC, China, US
Show more
Investment focus
  • Therapeutics, Biotechnology, Pharmaceutical
  • Series A
  • Finland
Portfolio highlights
  • Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Valio VC Fund · Helsinki, Southern Finland, Finland
We are Valio Group: the most innovative dairy and food company in the world.
Show more
Investment focus
  • Life Science, Biotechnology
  • Series A, Series B
  • Finland
Portfolio highlights
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Loudspring VC Fund · Helsinki, Southern Finland, Finland
Loudspring is a cleantech accelerator in the Nordic region, boasting several fast growing and high impact companies that solve global challenges. The portfolio companies are active in energy- and resource efficiency as well as decentralized renewable energy and are based in Finland, Sweden and Germany. The company management consists of companybuilders and investors who have been active within the cleantech space for over a decade.The company is listed on First North Finland under the ticker LOUD and on First North Stockholm under the ticker LOUDS.
Show more
Investment focus
  • SaaS, Smart Building, Property Management
  • Series A, Seed, Grant
  • Finland, United States
Portfolio highlights
  • Nuuka — Nuuka is a building SW scaleup from Finland. Nuuka specialises in diagnosing and optimising HVAC, energy systems, and indoor climate. The SaaS is optimal for large building portfolios, of new and old public and commercial buidlings, as it can be used with any BMS and HVAC system, IAQ sensor or energy meter. Nuuka improves indoor climate, energyefficiency, reduces operational cost and improves sustainability for real estate owners, developers, retail chains and whole cities. We use SW, AI and ML to transform and industry, and save the world one building at the time.
  • Swap.com — Swap is an online consignment and thrift store shop high-quality secondhand clothes. Shop the best brands at up to 90% off.
  • ResQ Club — ResQ Club is a Finnish company connecting sustainable restaurants, cafes, and grocery stores with consumers that appreciate eating affordable quality food. ResQ partners can drastically reduce their food waste with their proprietary location-based mobile and web service, as it enables consumers to find and rescue surplus food in their proximity.Every meal purchased via ResQ is one less meal thrown away, helping their urban communities to waste less and be more sustainable.They are on a mission to reduce food waste to zero at restaurants, cafes, and grocery stores. It's estimated that 10% of the already produced food in restaurants ends up in the trash instead of hungry mouths. On a global scale, this equals 11 million tons of food wasted every year.
Moomin Characters VC Fund · Helsinki, Southern Finland, Finland
Moomin Official Site: discover Moominvalley and the magical characters created by Tove Jansson. Get the latest Moomin news and stories.
Show more
Investment focus
  • Biotechnology, Environmental Engineering
  • Seed
  • Finland
Portfolio highlights
  • Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.
Kiilto Ventures VC Fund · Helsinki, Southern Finland, Finland
Kiilto Ventures is a family-owned company. Kiilto invests strongly in growth and renewal, determined to keep on reinventing and challenging themselves beyond their present core business.
Show more
Investment focus
  • Construction, CRM, Hospital
  • Funding Round, Seed
  • Finland, Portugal
Portfolio highlights
  • Delox — Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions,catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination.
  • Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
  • Asumma Homes — Asumma Homes is a construction technology company that focuses on building a global brand in housing. It provides architectural design, configuration, customization, and construction engineering. Asumma Homes was founded in the year 2021.
XR Invest VC Fund
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more
Investment focus
  • Medical Device, Sensor, Medical
  • Series A, Series C, Funding Round
  • Finland, United States
Portfolio highlights
  • Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
  • Synoste Oy — Patient friendly and innovative solutions for correcting skeletal deformations.
KPMG VC Fund · Amstelveen, Noord-Holland, The Netherlands · 2 investments in the past 12 months
KPMG is a global network of professional firms providing Audit, Tax & Advisory services.
Show more
Investment focus
  • Software, Information Technology, Enterprise Software
  • Funding Round, Series A, Series B
  • United States, Australia, United Kingdom
Portfolio highlights
  • Auditoria.AI — Auditoria's agentic AI-based finance automation increases the speed, accuracy, and productivity of teams to automate accounts payable and receivable.
  • Wokelo AI — Wokelo AI transforms research for PE, VC, Consulting, and Corporates. Save time, uncover insights, and make data-driven decisions. Book your demo now.
  • Unblock — Unblock is building a free, white-labelled, instant and local on and off-ramp to stable cryptocurrencies.
Unifund VC Fund
Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.
Show more
Investment focus
  • Software, Collaboration, Management Consulting
  • Funding Round
  • Finland
Portfolio highlights
  • Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
  • PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Haakon Overli Angel · London, England, United Kingdom
Dawn is Europe’s largest specialist B2B software investor, with assets under management of $1.5bn. Dawn partners with founders building the next generation of global software leaders, supporting them to harness extraordinary teams.Haakon has served on the boards of Self Trade and Wonga.com amongst others, and currently represents Dawn’sinterest at Conversocial, Crate.io, LeadDesk, Minute Media and Neo Technologies.Prior to formalising early stage investing at Dawn, Haakon worked with early stage companies from their first commercial efforts through to managing accelerated growth, often by serving as an interim manager or board member. They include G-Cluster (sold to Softbank Broadmedia) and Lateral Logic (sold to Electronic Arts).Mr. Overli studied Mathematics at the University of Oslo and holds a B.A. (Hons) in Economics from University of Durham.In his investment-banking career when the world was covered in ice, Haakon was a Director and Co-Head of Technology Investment Banking at ING Barings. Prior even to that, Haakon worked for JP Morgan in the M&A departments of New York and London.
Show more
Investment focus
  • Advertising, SaaS, Software
  • Series A, Series B, Series C
  • United States, United Kingdom, Finland
Portfolio highlights
  • Minute Media — We are a digital-first media company with a global footprint, bringing passion to life with proprietary technology that powers best-in-class content and advertising partnerships.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
  • Crate.io — CrateDB is the leading open-source, distributed SQL database, empowering customers to turn data into business value
Eqvitec VC Fund · Helsinki, Southern Finland, Finland
Eqvitec Partners is a privately owned and independent Nordic private equity firm, advising six funds with a total capital base of over €500 million. Equity funds invest in technology companies in all phases from early-stage to buyouts. Mezzanine funds focus on buyouts and expansion financing.Eqvitec Partners offers a combination of experienceand expertise to companies with an attractive business model and solid growth potential. They spend a lot of time with the portfolio companies working closely with the management on a board level. Their aim is to add significant value, particularly via intellectual capital, with a focus on strategy implementation and business development. In addition, they bring a significant network and financial know-how to their portfolio companies. Eqvitec funds typically exit the investments after 3-6 years through a trade sale or a stock exchange floatation.Eqvitec Partners was established in 1997 and currently has 15 employees in the Helsinki and Stockholm offices.They are a member of the Finnish Venture Capital Association (FVCA), Swedish Venture Capital Association (SVCA), European Private Equity and Venture Capital Association (EVCA) and Nordic Venture Network (NVN).
Show more
Investment focus
  • Software, Information Technology, Enterprise Software
  • Funding Round, Series A, Seed
  • Finland, Sweden, United Kingdom
Portfolio highlights
  • Norstel — Norstel AB manufactures and develops wide bandgap semiconductor materials, including silicon carbide (SiC) wafers and epitaxial layers.
  • eBuilder — eBuilder is a global company that optimizes and automates administrative processes for corporations and public sector agencies through IT-based business process outsourcing.
  • MediSapiens — MediSapiens provides software solutions to clients in the biomedical field. Our solutions turn biomedical data into new insights and knowledge. Our clients
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 5 investments in the past 12 months
Our primary focus is on the development of novel therapeutics and platforms. We balance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capitalefficiency in the program.We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company:tm:s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 30 to 50 mio per company over its life, but it can be as little as 100'000 USD to get started. We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates. SectorsNew therapeutics & platformsMedical devices/implantsDiagnostics/biomarkersDrug delivery/biopolymersGeographyUSA/CanadaEuropeSwitzerlandAsia/Pacific
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
  • Hepalink — Hepalink is a manufactures ultra-pure pipeline control systems based on semiconductors and pan-semiconductor liquid circuits.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
K5 Global VC Fund · Los Angeles, California, United States · 11 investments in the past 12 months
K5 Global is a new media and financial services advisory and consulting firm. The company works with corporations, government entities, and start-ups, and is involved in a range of industries, including sports, technology, politics, and entertainment. K5 functions as a liaison for high-level startups and deal flow, connects influencers andcelebrities to entrepreneurs and brands, and incubates global business opportunities with A-list talent.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Series A, Seed, Series B
  • United States, Brazil, Israel
Portfolio highlights
  • Quindar — Satellite Mission Management for startups. Operate faster than your competition.
  • Few and Far — Few and Far is the next-generation platform for experiences in Web3, including NFTs, DeFi, gaming, and more. They help NFT projects with launchpad services, minting tools, outbound marketing, and more. They offer creators the liquidity, ability to earn, and listings alongside the top collections on NEAR.
  • Product Science — Product Science increases product metrics for mobile applications and helps apps work faster by providing insights into key performance issues that impact user experience.
Feroz Dewan Angel
Feroz Dewan is the chief executive officer at Arena Holdings.
Show more
Investment focus
  • Life Science, Market Research, Quantum Computing
  • Seed
  • Finland
Portfolio highlights
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Creathor Ventures VC Fund · Bad Homburg, Hessen, Germany
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Funding Round, Series B
  • Germany, Switzerland, United States
Portfolio highlights
  • Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
  • HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
  • Humanoo — HUMANOO | MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy.
Green Campus Innovations Oy VC Fund · Helsinki, Southern Finland, Finland
Provide an effective, outsourced incubation and acceleration platform .
Show more
Investment focus
  • Electric Vehicle, Manufacturing, Energy
  • Funding Round, Seed, Pre-Seed
  • Finland, Norway
Portfolio highlights
  • Akkurate — Sandvik Battery Electric Loaders and Trucks TH550B LH518B Mobile Charging Station Battery as a Service
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
  • The Human Touch Robotics — Automating online grocery and food related goods picking with single-item picking robots, through adaptive gripping and AI vision system.
HTGF (High-Tech Gruenderfonds) VC Fund · Bonn, Nordrhein-Westfalen, Germany · 34 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
  • nuuEnergy — nuuEnergy is a tech-enabled solution aiming to revolutionize the heat pump installation industry. By leveraging technology and industry expertise, we streamline the purchasing and installation process. Our unique approach, refinanced through innovative strategies, promotes a self-reliant and carbon-neutral lifestyle for all our customers.
  • Steuerboard — Steuerboard serves as a collaborative platform facilitating digital interaction between tax advisors and clients. The mission of Steuerboard is to rethink the way accountants and clients work together.
Ananda Impact Ventures VC Fund · Munich, Bayern, Germany · 6 investments in the past 12 months
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Germany, United Kingdom, Finland
Portfolio highlights
  • Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
  • Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
  • NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!
Aqua Spark VC Fund · Utrecht, Utrecht, The Netherlands
Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world. The small-to-medium enterprises (SMEs) they invest in are working toward the production of safe, accessible aquatic life, such as fish, shellfish and plants, in ways that do not harm their oceans. Their investors value the fact that each investmentaims to create triple impact—specifically, each investment is chosen for its potential to generate significant financial returns while also activating positive environmental and social outcomes.Aqua-Spark believes that committing to a long-term vision is the way to realize effective and lasting impact results. When it comes to investments, they do not seek quick exits; instead, they look for entrepreneurs who strive to build and scale toward the future, who see their business as major economic opportunities that can also help solve looming environmental and food security challenges over the long-term. As an essential of each investee, Aqua-Spark seeks sustainability.
Show more
Investment focus
  • Biotechnology, Aquaculture, Seafood
  • Funding Round, Series A, Seed
  • United States, Norway, Israel
Portfolio highlights
  • Oceano Fresco — Oceano Fresco develops and produces bivalves varieties with superior performance for shellfish farmers at a competitive cost, respecting environmental sustainability and ensuring consumer safety.They use a multi-disciplinary approach including expertise in molecular biology, genetics, animal physiology, computational biology and intellectualproperty to select value adding traits to shellfish farmers and contribute to the sustainability and profitability of the aquaculture industry.They work with hatcheries, nurseries and research centers in order to test and validate their solutions and ensure that they suit the specific needs of each customer, in each technical and environmental context.
  • Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.
  • Wanda Fish Technologies — Wanda Fish is an innovative FoodTech company with a platform that produces a wide variety of delicious fish fillets using sustainable cell-cultivation practices.
CPT Capital VC Fund · London, England, United Kingdom · 2 investments in the past 12 months
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more
Investment focus
  • Food and Beverage, Food Processing, Biotechnology
  • Series A, Seed, Series B
  • United States, Israel, United Kingdom
Portfolio highlights
  • ENOUGH — ENOUGH makes protein sustainable by producing ABUNDA mycoprotein, made by fermenting fungi with the natural sugars from grains. It is a whole protein with all 9 essential amino acids & rich in fibre. It is a B2B ingredient, neutral in taste and fibrous in texture, like meat. The most sustainable
  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • Wanda Fish Technologies — Wanda Fish is an innovative FoodTech company with a platform that produces a wide variety of delicious fish fillets using sustainable cell-cultivation practices.
Athensmed VC Fund
Athensmed Oy
Show more
Investment focus
  • Health Care, Medical, mHealth
  • Seed, Series A, Funding Round
  • Finland
Portfolio highlights
  • VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Stockholm Techstars Accelerator VC Fund · Stockholm, Stockholms Lan, Sweden
The Stockholm Techstars Accelerator invests in early-stage, high-growth companies looking to build and expand in the Nordic-Baltic startup ecosystem.
Show more
Investment focus
  • Pet, FinTech, Finance
  • Pre-Seed
  • Israel, Norway, Sweden
Portfolio highlights
  • goscore — Fair human credit scoring, credit check, and assessment for you
  • Terrawaste — TerraWaste is a next-generation chemical recycling company that turns non-recyclable waste into value by creating new, climate-positive materials with a pollution-free process. TerraWaste focuses on lowering the level of need for virgin oil extraction by recycling plastics with chemical recycling technology 'htloop' into high-qualityclimate-positive crude oil, biochar, and high-value chemicals to support companies globally to become more sustainable and circular. Our technology (htloop) is developed on a process developed in the laboratory for over 20 years and hasn’t been commercialized until recently. TerraWaste is the first company to use HTL to recycle plastic waste and turn it into new plastic products. The unique thing is the state-of-the-art technological system that will recycle waste in a continuous-flow system, at the same time reusing heat and water in a loop, that way dramatically decreasing energy consumption. Our process is pollution free, and we produce carbon-negative output materials, that way offsetting other, carbon-heavy industries.
  • Five Letter Foods — Real food for dogs. Ultra-processed junk food is boring and makes your dog sick. Our meal kits have a full swing of variety. Death to kibble.
University of Helsinki VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
Show more
Investment focus
  • Apps, Hospital, Consulting
  • Seed, Grant, Pre-Seed
  • Finland, Luxembourg
Portfolio highlights
  • NADMED — The standard of NAD measuring
  • Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Petri Pöyhönen Angel · Helsinki, Southern Finland, Finland
Petri Pöyhönen
Show more
Investment focus
  • Medical, Biotechnology, Medical Device
  • Series A
  • Finland
Portfolio highlights
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
H&M Group Ventures VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in the past 12 months
H&M Group Ventures is the venture capital arm of the H&M Group.
Show more
Investment focus
  • E-Commerce, Fashion, Textiles
  • Funding Round, Series A, Series B
  • Sweden, United States, United Kingdom
Portfolio highlights
  • Voyado — All-in-one CRM, CDP, marketing software and AI-powered product discovery purely built for retail and ecommerce.
  • Cult Mia — Your guide to designer discovery. We handpick the best fashion from around the world and bring it to you weekly. Our exclusive curated drops feature the most exciting new brands & unique pieces. This is power dressing with staying power.
  • Heirloom — Heirloom is restoring balance to our atmosphere by removing 1 billion tons of carbon dioxide by 2035. We use natural processes to engineer the world's most cost-effective Direct Air Capture solution.
Granström Mari Angel
Granström Mari is the Chief Science Activist at Origin by Ocean.
Show more
Investment focus
  • Biotechnology, Environmental Engineering
  • Seed
  • Finland
Portfolio highlights
  • Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.
Investors by industry
Investors by country
Investors in Finland by industry